WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife News Network.
1 minute reading time (125 words)

GW Pharma's cannabis drug gets orphan drug status – Marijuana News

The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.

GW said on Thursday that its drug, Epidiolex, had been granted the status for the treatment of tuberous sclerosis complex (TSC), a rare genetic disorder that causes epilepsy in about 80 percent to 90 percent of the patients afflicted with it.

TSC is the third orphan indication that GW is targeting within its Epidiolex clinical development program.

Orphan status is granted to drugs aimed at treating rare diseases, giving the developer incentives such as a seven-year marketing exclusivity in the United States.

Click here to read the rest of the article

Reuters ~

×
Stay Informed

When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.

Fresh off White House visit, DC cannabis group wan...
Congress: Lots of Talk, No Action On Marijuana – M...

Related Posts


WeedLife.com